Royal Bank Of Canada Glaukos Corp Transaction History

Royal Bank Of Canada

  • $479 Billion
  • Q4 2024

A detailed history of Royal Bank Of Canada transactions in Glaukos Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 112,310 shares of GKOS stock, worth $14.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
112,310
Previous 131,151 14.37%
Holding current value
$14.1 Million
Previous $17.1 Million 1.45%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$126.42 - $152.67 $2.38 Million - $2.88 Million
-18,841 Reduced 14.37%
112,310 $16.8 Million
Q3 2024

Nov 14, 2024
SELL
$113.62 - $135.39 $2.31 Million - $2.76 Million
-20,363 Reduced 13.44%
131,151 $17.1 Million
Q2 2024

Aug 14, 2024
SELL
$89.48 - $118.35 $4.14 Million - $5.48 Million
-46,296 Reduced 23.4%
151,514 $17.9 Million
Q1 2024

Nov 05, 2024
BUY
$76.4 - $96.33 $3.54 Million - $4.46 Million
46,296 Added 30.56%
197,810 $18.7 Million
Q1 2024

May 15, 2024
SELL
$76.4 - $96.33 $4.17 Million - $5.26 Million
-54,558 Reduced 21.62%
197,810 $18.7 Million
Q4 2023

Feb 14, 2024
BUY
$59.53 - $85.11 $1.02 Million - $1.46 Million
17,141 Added 7.29%
252,368 $20.1 Million
Q3 2023

Nov 14, 2023
BUY
$69.23 - $79.09 $374,465 - $427,797
5,409 Added 2.35%
235,227 $17.7 Million
Q2 2023

Aug 14, 2023
BUY
$45.44 - $71.21 $583,585 - $914,550
12,843 Added 5.92%
229,818 $16.4 Million
Q1 2023

May 15, 2023
BUY
$43.88 - $52.48 $1.05 Million - $1.26 Million
23,937 Added 12.4%
216,975 $10.9 Million
Q4 2022

Feb 14, 2023
BUY
$40.82 - $57.75 $71,884 - $101,697
1,761 Added 0.92%
193,038 $8.43 Million
Q3 2022

Nov 14, 2022
BUY
$46.84 - $58.49 $78,691 - $98,263
1,680 Added 0.89%
191,277 $10.2 Million
Q2 2022

Aug 15, 2022
BUY
$34.86 - $63.77 $819,593 - $1.5 Million
23,511 Added 14.16%
189,597 $8.61 Million
Q1 2022

May 16, 2022
SELL
$44.33 - $57.82 $559,222 - $729,399
-12,615 Reduced 7.06%
166,086 $9.6 Million
Q4 2021

Feb 14, 2022
SELL
$40.27 - $56.99 $1.29 Million - $1.83 Million
-32,082 Reduced 15.22%
178,701 $7.94 Million
Q3 2021

Nov 15, 2021
BUY
$47.43 - $84.23 $2.24 Million - $3.98 Million
47,195 Added 28.85%
210,783 $10.2 Million
Q2 2021

Aug 16, 2021
BUY
$73.06 - $97.7 $12 Million - $16 Million
163,588 New
163,588 $13.9 Million

Others Institutions Holding GKOS

# of Institutions
354
Shares Held
50M
Call Options Held
282K
Put Options Held
401K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $5.99B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email